What is AnaptysBio, Inc.'s operating lease liabilities?

AnaptysBio, Inc. (ANAB) reported operating lease liabilities of $11.49M in Q1 2026.

How has AnaptysBio, Inc.'s operating lease liabilities changed year-over-year?

AnaptysBio, Inc.'s operating lease liabilities decreased by 15.6% year-over-year, from $13.61M to $11.49M.

What does operating lease liabilities mean?

Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.

AnaptysBio, Inc. ANAB Operating Lease Liabilities

Operating Lease Liabilities at other companies

BiogenBIIB

$273.4M-15.5%

Dianthus TherapeuticsDNTH

$965K-17.5%

AbCellera Biologics Inc.ABCL

$134.31M+112%

Apogee Therapeutics, Inc.APGE

$4.91M-37.4%

BridgeBio PharmaBBIO

$14.22M+189%

PrecigenPGEN

$3.66M-18.4%

Other financials

Income statement

See full

Revenue$25.6M-8.0%

Operating income-$34.6M-25.8%

Net income-$52.9M-34.5%

EPS (diluted)-$1.84-43.8%

Balance sheet

See full

Cash & equivalents$248.5M+152%

Total debt$13.6K-99.9%

Total equity$12.7M-62.5%

Total assets$329.7M-21.9%

Cash flow

See full

Operating cash flow-$25.9M-142%

CapEx$17.0K-51.4%

Free cash flow-$25.9M-142%

Valuation

See full

Market cap$1.73B+180%

Enterprise value$1.48B+176%

P/S7.4×+1.9×

Profitability

See full

Operating margin17.6%+9.6pp

Net margin-49.9%-22.6pp

FCF margin1.9%+1.0pp

Returns & leverage

See full

Return on equity-343.8%-1,012pp

Debt / equity0×-0.5×

Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AnaptysBio, Inc.'s operating lease liabilities?: AnaptysBio, Inc. (ANAB) reported operating lease liabilities of $11.49M in Q1 2026.
How has AnaptysBio, Inc.'s operating lease liabilities changed year-over-year?: AnaptysBio, Inc.'s operating lease liabilities decreased by 15.6% year-over-year, from $13.61M to $11.49M.
What does operating lease liabilities mean?: Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.